News and events

NewBiologix Presents New Data at ASGCT on the Effective Manufacturing of rAAV-based therapeutics

Interview of Igor Fisch in PharmaBoardroom

NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to Recipharm Advanced Bio for Development and Manufacture of Adeno-Associated Virus (AAV) Therapeutics

Advancing AAV Manufacturing Quality

Rewards in the Real World: Sitting Down With Igor Fisch

Scaling Platform Delivery of Gene Therapies: An Interview with NewBiologix's CEO Igor Fisch

NewBiologix Announces Scientific White Paper on Improving the Manufacturing of Recombinant Adeno-Associated Viruses for Use in Cell & Gene Therapies

NewBiologix Launches U.S. Subsidiary and Welcomes Gene and Cell Therapy Expert David Kelly as Business Development Manager

NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Improve and Accelerate Gene Therapy Development